Related Experiment Videos
The interaction between PAF, platelets and eosinophils in bronchial asthma
1Dept of Pharmacology, King's College, Chelsea Campus, University of London, U.K.
The European Respiratory Journal. Supplement
|June 1, 1989
Summary
Platelet activating factor (PAF) plays a key role in asthma pathogenesis, mimicking symptoms like airway hyperreactivity and inflammation. Targeting PAF may offer new therapeutic strategies for asthma.
Area of Science:
- Allergy and immunology
- Respiratory medicine
- Pathophysiology
Background:
- Asthma pathogenesis is complex, involving more than just airway smooth muscle contraction.
- Platelet activating factor (PAF) significantly contributes to asthma-like symptoms and pathological changes.
Purpose of the Study:
- To investigate the role of Platelet Activating Factor (PAF) in the pathogenesis of bronchial asthma.
- To explore the mechanisms underlying PAF-induced bronchial hyperreactivity (BHR).
Main Methods:
- Review of existing literature on PAF's role in asthma.
- Analysis of studies using selective PAF antagonists in experimental models and human subjects.
Main Results:
- PAF mimics key asthma features: bronchial hyperreactivity, eosinophil recruitment, mucus secretion, and smooth muscle hyperplasia.
- PAF antagonists confirm PAF's central role in allergic responses in animals and human skin.
Conclusions:
- PAF is a critical mediator in asthma pathogenesis, influencing multiple disease characteristics.
- Further research into PAF, platelets, and eosinophils interactions is crucial for understanding asthma.
- Targeting PAF pathways presents a promising therapeutic avenue for asthma management.